Institutional investors purchased a net $6.2 million shares of LIFE during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 52.24% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
REDMILE GROUP LLC Bought 1.9 Million shares of aTyr Pharma Inc
VIKING GLOBAL INVESTORS LP Bought 1.8 Million shares of aTyr Pharma Inc
ECOR1 CAPITAL LLC Bought 1.6 Million shares of aTyr Pharma Inc